TLR3 signaling does not affect organ-specific immune responses to factor IX in AAV gene therapy.
Cao
Ou
O
Herzog
Roland W
RW
D000256:Adenoviridae / Q000235:genetics / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D005164:Factor IX / Q000276:immunology*; D015316:Genetic Therapy / Q000009:adverse effects* / Q000379:methods; D005822:Genetic Vectors / Q000276:immunology; D006801:Humans; D051379:Mice; D009928:Organ Specificity / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D051196:Toll-Like Receptor 3 / Q000276:immunology*
C519703:TLR3 protein, mouse; D051196:Toll-Like Receptor 3; D005164:Factor IX